Dave Sirois | Director, Corporate Accounting & SEC Reporting |
James Green | Chairman of the Board, President & Chief Executive Officer |
Jennifer Cote | Interim Chief Financial Officer |
Bruce Jackson | Benchmark Company |
Paul Knight | KeyBanc |
Good day, and thank you for standing by. Welcome to Harvard Bioscience First Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Dave Sirois, Director of -- SEC Director. Please go ahead.